Streetbeat News

Analyst Ratings

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) has received various analyst ratings in the last quarter, with 6 bullish, 3 somewhat bullish, and 7 indifferent. Over the past 3 months, 16 analysts have offered 12-month price targets for the company, with an average price target of $121.62, a 1.98% decrease from the previous average price target of $124.08.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:01 pm

SBUX

Starbucks's (NASDAQ:SBUX) short percent of float has risen 8.8% since its last report, with 15.27 million shares sold short, which is 1.36% of all regular shares available for trading. It would take traders 2.4 days to cover their short positions on average. The company has less short interest than most of its peers, with an average of 9.55% for its peer group.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:01 pm

ROST

Ross Stores's (NASDAQ:ROST) short percent of float has fallen 53.96% since its last report, with 2.68 million shares sold short, which is 0.93% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. Ross Stores's short interest as a percentage of float is lower than its peer group average of 17.21%.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:00 pm

PTCT

15 analysts have provided ratings for PTC Therapeutics (NASDAQ:PTCT) in the last quarter. The ratings include 4 bullish, 3 somewhat bullish, 5 indifferent, 2 somewhat bearish, and 1 bearish. The average price target is $55.2, compared to the current price of $40.735, implying an upside. The average price target has increased by 0.36% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:00 pm

QCOM

Qualcomm's (NASDAQ:QCOM) short percent of float has risen 31.03% since its last report, with 12.65 million shares sold short, which is 1.14% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. However, compared to its peers, Qualcomm has less short interest as a percentage of float, which is 4.80% on average.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:00 pm

IIPR

Over the past 3 months, 5 analysts have published their opinion on Innovative Ind Props (NYSE:IIPR) stock. The average price target for the stock is $87.4, a decrease of 25.14% from the previous average price target of $116.75.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:00 pm

GMDA

Gamida Cell (NASDAQ:GMDA) has received mostly bullish ratings from analysts in the last quarter, with 6 bullish, 2 somewhat bullish, and 1 indifferent rating. The company's average 12-month price target is $7.22, a slight decrease from the previous average of $7.25.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:00 pm

VIPS

Vipshop Holdings (NYSE:VIPS) has received various analyst ratings in the last quarter, with 4 bullish, 2 somewhat bullish, and 1 indifferent. Over the past 3 months, 7 analysts have offered 12-month price targets for Vipshop Holdings, with an average price target of $17.96. This average price target has increased by 12.04% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 8:00 pm

WFC

A significant amount of unusual options activity has been observed for Wells Fargo (NYSE:WFC), with a majority of investors taking a bullish stance. Whales have been targeting a price range from $37.5 to $50.0 for Wells Fargo over the last 3 months. The price of WFC is up 0.74% at $42.77. Citigroup, RBC Capital, and Morgan Stanley have all provided their ratings and price targets for Wells Fargo.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 7:46 pm

AAPL

Apple's shares are trading higher following Citi's initiation of coverage on the stock with a Buy rating and a price target of $240. Apple reached a $3 trillion market cap on Friday.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 7:09 pm